A Water-soluble Homodimeric Serine Palmitoyltransferase from Sphingomonas paucimobilis EY2395T Strain

PURIFICATION, CHARACTERIZATION, CLONING, AND OVERPRODUCTION*

Hiroko Ikushiro, Hideyuki Hayashi, and Hiroyuki KagamiyamaDagger

From the Department of Biochemistry, Osaka Medical College, Takatsuki, Osaka 569-8686, Japan

Received for publication, February 19, 2001, and in revised form, March 9, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Serine palmitoyltransferase (SPT, EC 2.3.1.50) is a key enzyme in sphingolipid biosynthesis and catalyzes the decarboxylative condensation of L-serine and palmitoyl-coenzyme A to 3-ketodihydrosphingosine. We found that the Gram-negative obligatory aerobic bacteria Sphingomonas paucimobilis EY2395T have significant SPT activity and purified SPT to homogeneity. This enzyme is a water-soluble homodimeric protein unlike eukaryotic enzymes, known as heterodimers composed of tightly membrane-bound subunits, named LCB1 and LCB2. The purified SPT shows an absorption spectrum characteristic of a pyridoxal 5'-phosphate-dependent enzyme. The substrate specificity of the Sphingomonas SPT is less strict than the SPT complex from Chinese hamster ovary cells. We isolated the SPT gene encoding 420 amino acid residues (Mr 45,041) and succeeded in overproducing the SPT protein in Escherichia coli, in which the product amounted to about 10-20% of the total protein of the cell extract. Sphingomonas SPT shows about 30% homology with the enzymes of the alpha -oxamine synthase family, and amino acid residues supposed to be involved in catalysis are conserved. The recombinant SPT was catalytically and spectrophotometrically indistinguishable from the native enzyme. This is the first successful overproduction of an active enzyme in the sphingolipid biosynthetic pathway. Sphingomonas SPT is a prototype of the eukaryotic enzyme and would be a useful model to elucidate the reaction mechanism of SPT.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Sphingolipids are ubiquitous membrane components having a backbone structure called long-chain base (LCB)1 which is N-fatty acylated and linked to various polar head groups. In eukaryotes, sphingolipids such as sphingosine, sphingosine 1-phosphate, and ceramide are known to play important roles as second messengers in various cellular events including proliferation, differentiation, senescence, apoptosis, and immune response (1).

Serine palmitoyltransferase (SPT: EC 2.3.1.50) catalyzes the pyridoxal 5'-phosphate (PLP)-dependent condensation reaction of L-serine with palmitoyl-coenzyme A (CoA) to generate 3-ketodihydrosphingosine (KDS). This reaction is the first committed step in sphingolipid biosynthesis, utilizing substrates that are shared by other metabolic pathways, and has an activity lower than those of other enzymes involved in sphingolipid biosynthesis. Therefore, SPT is thought to be a rate-determining enzyme in the sphingolipid synthetic pathway and, accordingly, a key enzyme regulating the cellular sphingolipid content (2). Eukaryotic SPTs have been known as membrane-bound proteins, enriched in the endoplasmic reticulum with their catalytic sites facing the cytosol (3). Genetic studies have shown that two different genes, LCB1 and LCB2, are required for SPT activity in the yeast Saccharomyces cerevisiae (4-6). Subsequently, mammalian homologues of the LCB genes from mouse, human, and Chinese hamster ovary cells have also been reported (7-9). The biochemical studies using the Chinese hamster ovary cell mutants demonstrated that both the LCB1 and LCB2 proteins are subunits of SPT (10, 11). There is a high sequence homology between LCB1 and LCB2, and they are classified as new members of the PLP-dependent alpha -oxamine synthase subfamily (6). Based on the finding that LCB1 does not have a PLP-binding motif while LCB2 carries a lysine residue expected to form a Schiff base with PLP, LCB1 and LCB2 have been speculated as a regulatory unit and a catalytic unit, respectively (6, 10, 11). There is, however, no biochemical explanation for the regulation mechanism of the SPT reaction at present. The purification of the native form SPT from any eukaryotes has not been successful because of the extremely low content and instability of this enzyme. We, too, tried to construct the expression system of the mouse SPT complex in Escherichia coli (12). Affinity tagged forms of mouse LCB proteins lacking the membrane-anchor regions were coexpressed in E. coli as partially soluble proteins, but the purified SPT complex did not show enzymatic activity. As the only achievement, Hanada et al. (11) obtained an active SPT complex from the Chinese hamster ovary cell mutants expressing a hexahistidine-tagged LCB1 protein. However, it is very difficult to obtain a sufficient amount of the active enzyme for detailed enzymological analysis from such purification sources.

Although sphingolipids are not typical membrane constituents in prokaryotes, there are some exceptions. In strict anaerobes such as the genera Bacteroides, Porpthyromonas, and Prevotella, high levels of sphingolipids were found; in some species their contents in the total extractable lipid came to 70% (13, 14). It has been reported that Bacteroides melaninogenicus contains a water-soluble SPT, but the purification of this enzyme was not successful (15). The Gram-negative obligatory aerobic bacteria Sphingomonas and Sphingobacterium are the genera whose lipid composition and structure of their sphingolipids have been investigated most extensively (16, 17). In cells of Sphingomonas paucimobilis, the lipopolysaccharide in their outer membrane is completely substituted by sphingoglycolipid, and its proposed structure is 1-O-D-glucuronosyl-2-N-2'-hydroxymyristoyldihydrosphingosine (glucuronosyl ceramide) (18, 19).

We found that cells of S. paucimobilis EY2395T and Sphingobacterium spiritivorum EY3101T contain significant SPT activity and report here the purification to homogeneity and characterization of SPT from S. paucimobilis EY2395T. The primary structure of the enzyme has been deduced from the cloned gene, and the SPT protein was successfully overproduced in E. coli. The results show that SPT from S. paucimobilis is a prototype of eukaryotic enzymes.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chemicals-- L-Serine and other natural L-amino acids were obtained from Nacalai Tesque (Kyoto, Japan). Palmitoyl-CoA and lauroyl-CoA were from Funakoshi (Tokyo, Japan). Myristoyl-CoA, n-heptadecanoyl-CoA, stearoyl-CoA, arachidoyl-CoA, palmitoleoyl-CoA, oleoyl-CoA, O-phospho-L-serine, alpha -methyl-D,L-serine, and L-serine methylester were from Sigma. Serinol and serinamide were from Aldrich. 3-Hydroxypropionic acid was from Tokyo Kasei Kogyo (Tokyo, Japan). 4-(2-Aminoethyl)-benzenesulfonyl fluoride (AEBSF) was from Roche Molecular Biochemicals. The low molecular weight gel filtration calibration kit, gel filtration calibration kit, phenyl-Sepharose CL-4B, PD-10, SuperoseTM 12, and MonoQTM HR 5/5 were from Amersham Pharmacia Biotec. DEAE-Toyopearl 650M and Butyl-Toyopearl 650M were from Tosoh (Tokyo, Japan). The CHT-II Econo-PacTM cartridge was from Bio-Rad Laboratories. Competent E. coli JM109 was purchased from Nippon Gene (Tokyo, Japan). E. coli BL21(DE3) pLysS and plasmid pET21b were from Novagen. A plasmid pUC118 was from TaKaRa (Kyoto, Japan). All other chemicals were of the highest grade commercially available.

Bacterial Strains and Growth Conditions-- S. paucimobilis EY2395T and S. spiritivorum EY3101T were gifts from Dr. Eiko Yabuuchi, Aichi Medical University, Aichi, Japan. Each strain was grown in 1 liter of LB medium in 5-liter flasks at 30 °C and 90 rpm. Cells were harvested in the late exponential growth phase (after 8-9 h) and stored at -20 °C before use.

Assay of the Enzyme Activity-- In the purification steps, the SPT activity was measured according to the methods of Williams et al. (20) with minor modifications. The enzyme solution was incubated in 100 µl of a standard SPT reaction buffer (100 mM HEPES-NaOH buffer (pH 7.5) containing 0.1 mM EDTA, 5 mM dithiothreitol, 10 µM PLP, 0.4 mM palmitoyl-CoA, and 2 mM L-[3H]Ser (37 kBq/mmol)) at 37 °C for 10 min. The reaction was terminated by addition of 100 µl of 2 N NH4OH. The lipids were extracted with CHCl3/CH3OH (2:1 (v/v)), and the radioactivity of the [3H]KDS that formed was measured. The radioactivity extracted from enzyme-negative control was regarded as a background. For steady-state kinetic analysis, [14C]KDS was added to the extraction solvent as the internal standard to estimate recoveries throughout the entire procedure. [14C]KDS was enzymaticaly synthesized from [14C]serine using purified SPT. For TLC analysis, [14C]serine (10 kBq/mmol) or [14C]palmitoyl-CoA (10 kBq/mmol) was used as the substrate. The lipids were extracted and separated on TLC plates (Silica Gel 60, Merck) with a solvent of chloroform, methanol, and 2 N NH4OH (40:10:1 (v/v)). [14C]Dipalmitoylphosphatidylcholine was added to the extraction solvent as the internal standard. Radioactive lipids on the TLC plates were visualized and their relative radioactivity was determined using a BAS2000 Image AnalyzerTM (Fujifilm, Tokyo, Japan).

Purification of SPT-- All purification procedures were performed at 4 °C. The buffer of 20 mM potassium phosphate (pH 6.5) containing 0.1 mM EDTA, 5 mM dithiothreitol, 0.1 mM AEBSF (protease inhibitor), and 20 µM PLP was used in all the following procedures except for the fast protein liquid chromatography steps. The cells (30 g wet weight) were suspended in 300 ml of the buffer and disrupted sonically (Branson Sonic Power, Sonifier model 450) at 20 kHz for 9 min. The intact cells and debris were removed by centrifugation (10,000 × g, 40 min). After the addition of (NH4)2SO4 (final concentration, 30% saturation) and centrifugation (100,000 × g, 60 min), the supernatant solution was applied to a phenyl-Sepharose CL-4B column (2.5 × 20 cm) equilibrated with the buffer containing 30% saturated (NH4)2SO4. The enzyme activity was eluted with 1 liter of linearly decreasing (NH4)2SO4 concentrations (30 to 0%). After the addition of (NH4)2SO4 (final concentration, 30% saturation) again, the active fractions were applied to a Butyl-Toyopearl 650M column (2.5 × 20 cm) equilibrated with the buffer containing 30% saturated (NH4)2SO4. The enzyme activity was eluted with 1 liter of linearly decreasing (NH4)2SO4 concentrations (30 to 0%). The pooled active fractions were dialyzed against 2 liters of the buffer. The dialysate was then applied to a DEAE-Toyopearl 650M column (2.5 × 20 cm) equilibrated with the buffer. The enzymes were eluted with 1 liter of linear gradient from 0 to 500 mM NaCl. The pooled active fractions were concentrated and dialyzed against 1 liter of 10 mM potassium phosphate buffer (pH 6.5) containing 0.1 mM EDTA, 5 mM dithiothreitol, 0.1 mM AEBSF, and 20 µM PLP. The dialysate was applied to a CHT-II column (1.35 × 3.5 cm), which had been connected to a fast protein liquid chromatography system, equilibrated with the same buffer. The enzyme was eluted with a 50-ml linear gradient from 10 to 200 mM potassium phosphate (pH 6.5). The eluted enzyme was dialyzed against 1 liter of 50 mM Tris-HCl buffer (pH 7.5) and then applied to a Mono-QTM HR column (0.55 × 5 cm) equilibrated with the same buffer. The column was washed with 50 mM Tris-HCl buffer (pH 7.5) containing 150 mM NaCl and eluted with a 25-ml linear gradient from 150 to 200 mM NaCl (pH 7.5). The active fractions were combined, concentrated to 1 ml, filtered, and stored at 4 °C. When 30 g of cells were used as the starting material, 350 µg of a pure preparation of SPT was obtained.

Amino Acid Sequencing-- The purified enzyme (8.9 nmol) was carboxymethylated, desalted, and digested at 37 °C for 30 min with lysyl endopeptidase (33 pmol). The digested peptides were isolated by reversed-phase high performance liquid chromatography on a Cosmosil 5C18 AR-II column (2.0 × 150 mm) with a linear gradient from 0 to 60% acetonitrile containing 0.05% trifluoroacetic acid. The amino acid sequences were determined using a Hewlett Packard G1005A protein sequencing system.

Isolation and Sequencing of Genomic DNA Clones Encoding SPT-- Based on the amino acid sequences of the SPT peptides, we synthesized degenerate oligonucleotides to obtain partial DNA fragments encoding the SPT gene by PCR against genomic DNA from S. paucimobilis. The oligonucleotides were 5'-GA(TC)GC(TCAG)CC(TCAG)GA(TC)AT(TCA)GCICC-3' and 5'-GC(TCAG)GT(TG)AA(TGA)AT(AG)TA(TCAG)GG-3' corresponding to the amino acid sequences DAPDIAP and PYIFTA, respectively (Fig. 5, dashed lines). The genomic DNA of S. paucimobilis was prepared by a standard method (21). PCR was performed using LA Taq DNA polymerase (TaKaRa, Kyoto, Japan) under the following conditions: 30 cycles of 94 °C for 30 s, (40+ t) °C for 30 s, and 72 °C for 1 min, then 72 °C for 10 min, where t denotes that the annealing temperature was successively increased by 0.25 °C at each cycle. The PCR product was directly cloned into a pCRII vector (Invitrogen, Netherlands) and sequenced by the "Dye-Terminator Cycle Sequencing" kit and an ABI 373A DNA sequencer (PerkinElmer Life Sciences). To obtain the full-length SPT gene, a genomic DNA library (1 × 106 recombinants) was screened with the 32P-labeled PCR product (846 base pairs) as a probe. The library was constructed as follows. A genomic DNA from S. paucimobilis was partially digested by Sau3AI, 2.5-3.5-kilobase fragments were agarose gel-purified and ligated into BamHI-digested pUC118, and these constructs were used to transform E. coli JM109. Labeling of the probe and detection of hybridized fragments were performed using the BcaBESTTM labeling kit (TaKaRa, Kyoto, Japan) and Quick-HybTM hybridization solution (Stratagene), respectively. Twelve positive clones of the first screening were isolated. Restriction mapping and partial sequencing revealed that all 12 clones were derived from the same gene. The complete DNA sequence was determined for both strands of the three longest clones.

Gel Filtration-- The enzymes were applied to a SuperoseTM 12 and fractionated at a flow rate of 0.5 ml/min with an fast protein liquid chromatography system. Bovine pancreas ribonuclease A (Mr 13,700), bovine pancreas chymotrypsinogen A (Mr 25,000), hen egg ovalbumin (Mr 43,000), bovine serum albumin (Mr 67,000), rabbit muscle aldolase (Mr 158,000), bovine liver catalase (Mr 232,000), horse spleen ferritin (Mr 440,000), bovine thyroid thyroglobulin (Mr 669,000), E. coli aspartate aminotransferase (Mr 43,573 × 2), and E. coli branched-chain amino acid aminotransferase (Mr 33,962 × 6) were used as standard proteins.

Spectrophotometric Measurement-- The absorption spectra of SPT were recorded with a Hitachi spectrophotometer U-3300 at 25 °C. The buffer solution for the absorption measurements contained 50 mM HEPES-NaOH (pH 7.5) and 0.1 mM EDTA. SPT was equilibrated with the above buffer by gel filtration using a PD-10 (Sephadex G-25) column (Amersham Pharmacia Biotech) prior to the measurement.

Other Methods-- Protein concentration during the purification procedure was determined with a BCA protein assay kit (Pierce Chemical) using bovine serum albumin as a standard. The protein concentration of purified SPT was determined spectrophotometrically using a molar extinction coefficient of 2.83 × 104 M-1 cm-1 at 280 nm for the PLP form of the enzyme. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out with an SDS-Tris system using 10% polyacrylamide gel according to the procedure described by Laemmli (22).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

SPT Activity in S. paucimobilis and S. spiritivorum-- S. paucimobilis and S. spiritivorum contain a large amount of sphingolipids as their cell components (16, 17), and thus sphingolipid biosynthetic enzymes have been expected to exist in these bacteria. Cell-free extracts (100,000 × g supernatants) prepared by sonication of cells of these strains were examined for SPT activity by incubation with [14C]serine and unlabeled palmitoyl-CoA. The lipids were extracted and subjected to TLC analysis. Some radioactive products were detected for each extract (Fig. 1). One of these products was indistinguishable in migration from KDS formed by mouse liver microsomes. The cell fractionation experiment indicates that the SPTs of these bacteria are water-soluble enzymes (Fig. 1). Because the extracts of S. paucimobilis showed higher SPT activity than that of S. spiritivorum, S. paucimobilis was selected as the starting material for the purification of SPT.


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 1.   Thin-layer chromatography of radiolabeled products obtained by assays of SPT of mouse liver microsomes, S. paucimobilis, and S. spiritivorum. Lanes 1 and 4, mouse liver microsomes as a reference; lane 2, crude extract after sonication of S. paucimobilis; lane 3, the supernatant after centrifugation at 100,000 × g of S. paucimobilis crude extract; lane 5, crude extract after sonication of S. spiritivorum; lane 6, the supernatant after centrifugation at 100,000 × g of S. spiritivorum crude extract.

Purification of SPT from S. paucimobilis-- The enzyme was purified to homogeneity by five steps of column chromatography. As shown in Fig. 2, the purified SPT showed a single protein band with an apparent Mr of about 50,000 on SDS-PAGE. Cell-free extracts of S. paucimobilis contain a large amount of yellow pigment, which was very difficult to remove by the initial two hydrophobic column chromatographies. Table I summarizes the purification of SPT from the S. paucimobilis extract. About 350 µg of the protein could be obtained from 6 liters of S. paucimobilis culture. The purification yield was reproducibly over 100% probably because some coexisting inhibitory materials were removed as the purification proceeded. The purified enzyme could be stored at 4 °C in sterile capped vials for up to 2 months in 20 mM Tris-HCl buffer (pH 7.5) without loss of activity.


View larger version (89K):
[in this window]
[in a new window]
 
Fig. 2.   SDS-polyacrylamide gel electrophoresis at various steps of SPT purification. Lane 1, crude extract after sonication and centrifugation at 100,000 × g (20 µg of protein); lane 2, phenyl-Sepharose CL-4B column (10 µg of protein); lane 3, Butyl-Toyopearl column (5 µg of protein); lane 4, DEAE-Toyopearl column (5 µg of protein); lane 5, CHT-II (hydroxyapatite) column (1 µg of protein); lane 6, Mono-Q column (1 µg of protein). The samples (10 µl) were analyzed by SDS-polyacrylamide gel electrophoresis on a 10% gel and stained with the Coomassie Brilliant Blue R-250. Prestained Protein Marker, Broad Range, from New England Biolabs was used as the molecular mass standard.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Purification of SPT from S. paucimobilis

Physical Characterizations-- The Mr of the purified enzyme was estimated to be about 90,000 by gel filtration. Electrospray ionization mass spectrometry (ESI-MS) gave a signal at m/z 44,916. These results show that the native SPT from S. paucimobilis has a dimer structure composed of two identical subunits. The purified SPT had an absorption spectrum with two peaks at 338 and 426 nm other than the protein absorption peak at 278 nm in 50 mM HEPES-NaOH (pH 7.5) containing 0.1 mM EDTA (Fig. 3). These absorption peaks are characteristic of PLP enzymes, which contain the cofactor bound to the epsilon -amino group of a lysine residue in the active site (23). The addition of serine to the enzyme gave rise to an intense absorption band at 426 nm and a less intense band at 338 nm, which indicates that 338 nm absorption represents the active species and that the external aldimine complex was formed.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Absorption spectrum of purified SPT. The conditions were as follows: 50 mM HEPES-NaOH buffer, 0.1 mM EDTA, pH 7.5, 25 °C, 0.35 mg/ml enzyme.

Catalytic Properties and Substrate Specificity-- The time course of KDS formation by the purified SPT was almost linear for at least 20 min, and this activity was proportional to the amount of purified enzyme up to 100 ng under the reaction conditions mentioned above. The optimum pH for KDS formation was 7.5-8.0. SPT from S. paucimobilis was not inhibited by halide ions. No inhibition of SPT activity was found with relatively high concentrations of palmitoyl-CoA (up to 10 mM).

The substrate specificity is summarized in Tables II and III. To assess the specificity for amino acids, we determined the production of [14C]KDS derivatives from [14C]palmitoyl-CoA with 20 natural amino acids or various serine analogs. Purified SPT (50 ng) was incubated with 0.8 mM [14C]palmitoyl-CoA and 4 mM various amino as the substrate. The activity was detected only for serine among the natural amino acids examined (data not shown). Serine methylester and O-phosphoserine were converted to KDS at lower rates (5 and 3% of the mean levels of KDS formed with serine, respectively). However, at present, we cannot preclude the possibility that serine derived from serine methylester by hydrolysis was metabolized to KDS. We also examined the inhibition effect of excess amounts of nonradioactive competitors on the [3H]KDS production from 0.1 mM L-[3H]serine (Table II). [3H]KDS production was inhibited about 80% by 4 mM nonradioactive L-serine under this assay condition. The inhibition of the [3H]KDS production by 4 mM each of other natural amino acids except for cysteine was 40% or less. The effect of cysteine can be ascribed to the thiazolidine formation of cysteine with PLP (23). O-Phosphoserine was the most effective, with alpha -methyl-DL-serine, 3-hydroxypropionate, and serine methyester following in this order. Seriamide and serinol were essentially inert. Among various acyl-CoAs examined, palmitoyl-CoA was the best substrate (Table III). The unsaturated bond of the acyl chain of CoA analogs did not significantly influence the SPT activity. The activity chain length profile showed a bell-shaped pattern, which peaked around C16.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Effects of various amino acids on the formation of [3H]KDS from L-[3H]serine
Purified SPT (50 ng) was incubated with 0.1 mM L-[3H]serine, 0.8 mM palmitoyl-CoA and 4 mM of each nonradioactive competitor indicated. The levels of radioactivity of [3H]KDS that formed are shown as a percentage of the mean level of [3H]KDS formed in the absence of the competitors. The other natural amino acids were inert as competitors. Each value varied ±10% between experiments.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Acyl-CoA specificity of purified SPT
Purified SPT (50 ng) was used. The levels of KDS are shown as a percentage of the mean level of KDS formed with palmitoyl-CoA. Each value varied ±10% between experiments.

Kinetic Parameters of Native SPT-- Steady-state analysis of the purified SPT was carried out. The kinetic parameters for SPT were determined with respect to serine and palmitoyl-CoA. As shown in Fig. 4, the experimental data were analyzed according to the ordered Bi-Bi mechanism (24). The Km values for serine and palmitoyl-CoA were 4.2 and 0.87 mM, respectively, and the kcat value was 140 min-1 (Table IV).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 4.   Kinetic characterization of native SPT from S. paucimobilis. The enzyme assay was performed as described under "Experimental Procedures." [3H]Serine as the substrate and [14C]KDS as the internal standard were used. Panel A, the apparent rate constants (kapp) for the KDS formation were plotted as a function of palmitoyl-CoA concentration. Each solid line represents the theoretical curve according to the initial velocity equation on the ordered Bi-Bi mechanism using the kinetic parameters summarized in Table IV. Panel B, determination of K<UP><SUB><IT>m</IT></SUB><SUP>Ser</SUP></UP>, K<UP><SUB><IT>m</IT></SUB><SUP>Pal</SUP></UP>, and kcat. Primary plot of [palmitoyl-CoA]/kapp versus [palmitoyl-CoA] at various serine concentrations. The secondary substrate (serine) concentrations were 1 mM (closed circle), 2 mM (open circle), 4 mM (closed square), 10 mM (open square), 20 mM (closed triangle), 50 mM (open triangle). Inset, the secondary plot of [palmitoyl CoA]/kapp - ordinate intercept replot versus 1/[Ser].

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Kinetic parameters of purified SPT
The data for the native SPT are from Fig. 4. The data for the recombinant SPT were obtained by the same assay.

Cloning of the SPT Gene-- The nucleotide sequence of one of the three clones sequenced, SPT1 (GenBankTM accession number AB055142), is shown in Fig. 5. SPT1 contains a 1260-base pair open reading frame (65% GC content) encoding a protein of 420 amino acid residues. The amino-terminal protein sequence of purified SPT was Thr-Glu-Ala-Ala-Ala-, indicating that the first methionine of purified SPT had been cleaved by processing. The deduced amino acid sequence of SPT is also shown in Fig. 5. The molecular weight of 44,916 obtained by ESI-MS is in good agreement with the value of 44,910 calculated from the deduced amino acid sequence of SPT without the first methionine within experimental error.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 5.   Nucleotide and deduced amino acid sequences of S. paucimobilis SPT gene. The deduced amino acid sequence is given below the nucleotide sequence. The putative Shine-Dalgarno (SD) sequence is indicated by the double underline. The internal amino acid sequence of SPT determined by Edman degradation is indicated by the underline. The annealing sites of the oligonucleotides for the degenerate PCR cloning are indicated by the dashed underline. An asterisk marks the termination codon. An open circle marks the lysine residue predicted to bind PLP.

Sequence Comparisons-- The non-redundant data bases at the National Center for Biotechnology Information were scanned for amino acid sequences similar to the S. paucimobilis SPT sequence using the BLAST algorithm (25). The predicted S. paucimobilis SPT protein is related to proteins grouped as the alpha -oxamine synthase family. This gene family includes eukaryotic SPT subunits, 5-aminolevulinic acid synthase in heme biosynthesis, 8-amino-7-oxononanoate synthase (AONS) in biotin biosynthesis, and 2-amino-3-ketobutyrate-CoA ligase in the threonine utilization pathway, all of which catalyze chemically similar reactions using the cofactor PLP (26-30). The amino acid sequence alignment of S. paucimobilis SPT and mouse LCB1 and LCB2 proteins is shown in Fig. 6. Overall sequence homology is found between these proteins except for the NH2-terminal transmembrane region of mouse LCB proteins. SPT has 27% identity and 48% similarity with mouse LCB1 and 31% identity and 49% similarity with mouse LCB2. Fig. 7 shows the amino acid sequence alignment of S. paucimobilis SPT and three prokaryotic enzymes in the alpha -oxamine synthase family. There are 33% amino acid identity and 56% similarity between SPT and AONS of Bacillus sphaerious, 33% identity and 54% similarity between SPT and 2- amino-3-ketobutyrate-CoA ligase of Bacillus subtilis, and 36% identity and 55% similarity between SPT and 5-aminolevulinic acid synthase of Agrobacterium radiobacter.


View larger version (73K):
[in this window]
[in a new window]
 
Fig. 6.   Comparison of SPT protein sequences. The deduced amino acid sequence of SPT protein from S. paucimobilis SPT is compared with those of both LCB1 and LCB2 proteins from mouse. Alignment analysis was performed with GENETYX (Software Development Co., Fukuoka, Japan). Residues conserved among all proteins are fulltone-inverted and those conserved between the two of these members are halftone-inverted. An asterisk marks the lysine residue predicted to bind PLP. Triangles mark the residues corresponding to identified residues in the active site of AONS from E. coli (35).


View larger version (75K):
[in this window]
[in a new window]
 
Fig. 7.   Comparison of protein sequences of four PLP-dependent acyl-CoA transferases. The deduced amino acid sequence of SPT protein from S. paucimobilis SPT is compared with those of four of the PLP-dependent acyl-CoA transferases. Alignment analysis was performed with GENETYX. SPT, S. paucimobilis SPT; AONS, Bacillus sphaericus 8-amino-7-oxononanoate synthase; KBL, B. subtilis 2-amino-3-ketobutyrate CoA ligase; ALAS, A. radiobacter 5-aminolevulinic acid synthase. Residues conserved among all proteins are fulltone-inverted and those conserved among the three of those proteins are halftone-inverted. An asterisk marks the lysine residue predicted to bind PLP. Triangles mark the residues corresponding to identified residues in the active site of E. coli AONS.

Expression of the SPT Gene in E. coli-- In order to construct the expression system for S. paucimobilis SPT in E. coli, the internal NdeI restriction site (334ATGCAT) of SPT1 was changed to ATGCAC without changing the codons by site-directed mutagenesis, and the new restriction sites, NdeI and HindIII, were introduced to SPT1 at the translation initiation and termination sites, respectively, by PCR. The modified SPT1 was ligated into a pET21b vector, and the recombinant plasmid was used to transform E. coli BL21(DE3) pLysS cells. The SPT produced was functional, and the product amounted to about 10-20% of the total protein in the crude extract of E. coli. Because of the overproduction of the protein, the expressed SPT would be partially in the apo form, but it could be converted to the holoenzyme by addition of PLP to the cell lysate. The recombinant enzyme was purified to homogeneity using DEAE-Toyopearl, Butyl-Toyopearl, and hydroxyapatite column chromatographies. The recombinant SPT provided a 50-kDa band on SDS-PAGE (data not shown). The NH2-terminal sequence of the purified enzyme, Thr-Glu-Ala-Ala-Ala-, agreed with that of the native enzyme. Thus, the first methionine of the recombinant SPT was similarly removed by processing. The purified SPT showed a peak with m/z = 44,899 on ESI-MS, which is in agreement with the native SPT within experimental error. The catalytic properties of the recombinant SPT was the same as that of the native SPT; there is no significant difference between the two enzymes in their steady-state kinetic parameters (Table IV).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Because large scale cultivation of strict anaerobic bacteria is difficult and the unsuccessful purification of the B. melaninogenicus SPT has already been reported (15), we searched for aerobic bacteria containing sphingolipids and chose S. paucimobilis as an alternative purification source. S. paucimobilis contains sphingolipids which form more than 30% of the total extractable lipid (16, 19). There is a report that 14C-labeled fatty acids or amino acids were incorporated into the sphingolipids of S. paucimobilis (31). These findings suggest the possibility for this bacterium to contain SPT.

The most important finding is that the S. paucimobilis SPT is water-soluble and is a dimer composed of two identical subunits. All the eukaryotic enzymes examined so far are heterodimers, and both of the subunits are membrane-bound proteins. Membrane localization of eukaryotic SPT complexes seems reasonable because the product of this enzyme is a hydrophobic lipid incorporated into membranes. The relationship between cellular localization and the mechanism of the product release of bacterial SPT is the next subject of research. How is the reaction product, KDS, transferred to the membrane? Does SPT interact with membrane in vivo? Do other sphingolipid biosynthetic enzymes also exist as water-soluble forms in S. paucimobilis? As for the subunit composition, we can reasonably consider that bacterial SPTs are homodimers. Judging from the high sequence homology between LCB1 and LCB2, ancestral SPT would have been a homodimer, and the gene was duplicated at some point early in the evolution of eukaryotes. The functional benefit for the heterodimerization, or the role of the LCB1 subunit, however, remains unknown.

The purified enzyme showed an absorption spectrum characteristic of the PLP enzyme. The ratio in the peak height of the PLP-derived absorption bands (338 and 426 nm) to the protein-derived band (278 nm) indicates that SPT binds two PLP molecules per dimer. S. paucimobilis SPT is not inhibited by halide ions, although SPT activity of B. melaninogenicus has been reported to be significantly inhibited (15). The inhibition by high concentrations of palmitoyl-CoA, which has been observed for the eukaryotic enzymes, was not detected in S. paucimobilis SPT (Fig. 4) as well as in the B. melaninogenicus enzyme (11, 15, 32).

The substrate recognition of S. paucimobilis SPT was not so strict, especially for the acyl-CoA substrate, compared with the eukaryotic enzymes (11, 32). This observation might reflect the difference in the biological functions of sphingolipids between prokaryote and eukaryote. In eukaryotes, because sphingolipid metabolites take part in the intra- and intercellular signal transduction pathways, it would be necessary to regulate strictly their chemical structures and amounts by the synthetic enzymes. On the other hand, such physiological functions are not known for bacterial sphingolipids.

As shown in Table II, O-phosphoserine inhibited the [3H]KDS formation from L-[3H]serine as potently as the L-serine. This is consistent with the finding that O-phosphoserine was converted to a KDS derivative. Both serinamide and serinol, derivatives in which the carboxyl group of serine is modified, are not potent competitors of [3H]serine in the above reaction. The inhibitory effects of 3-hydroxypropionate and alpha -methyl-DL-serine agreed with the belief that they can form complexes with SPT, which mimic the Michaelis complex and the external aldimine, respectively. These results indicate that the carboxyl group of serine is essential for the recognition of the amino acid substrates by SPT.

Sequence comparison between the S. paucimobilis SPT and other prokaryotic enzymes of the alpha -oxamine synthase family shows that conserved amino acids are distributed throughout the entire sequence (Fig. 7). In addition to Lys-267 that forms a Schiff base linkage with PLP, catalytically important residues identified by x-ray crystallography on AONS from E. coli are completely conserved at the corresponding positions in SPT, such as His-159, Asp-231, and His-234 (Figs. 6 and 7, asterisk and triangles) (33). These residues interact directly with PLP, and His-159 and Asp-231 are also conserved in other PLP-dependent enzymes such as aspartate aminotransferases from various organisms.

We have succeeded in construction of the overproduction system of SPT in E. coli. The growth rate of E. coli was not inhibited even after the expression was induced, and the SPT overproduced was catalytically active. Until now, it has been thought that the toxicity of KDS, the reaction product of SPT, is one of the reasons why the expression system of SPT in E. coli cannot be constructed. However, the present results imply that KDS is not toxic to the E. coli host, or it is rapidly metabolized. The recombinant SPT was catalytically and spectrophotometrically indistinguishable from the native protein. There has been little success in the overproduction of the enzymes in the sphingolipid biosynthesis pathway, and almost no detailed research exists concerning the enzymatic characterization of these enzymes. This work permitted enough SPT for the three-dimensional structural analysis of this protein, which is essential for elucidation of the reaction mechanism of this enzyme. We are now attempting crystallization and x-ray diffraction studies of the S. paucimobilis SPT. Information obtained from the Sphingomonas enzyme would provide us with insight into the more complex eukaryotic homologue.

    ACKNOWLEDGEMENTS

We thank Dr. T. Nakanishi for ESI-mass spectroscopic analysis and Dr. E. Yabuuchi for the generous gifts of S. paucimobilis EY2395T and S. spiritivorum EY3101T. We also thank Dr. T. Yano for helpful discussions and critical reading of the manuscript.

    FOOTNOTES

* This work was supported by a Research Grant from the Japan Society for the Promotion of Science ("Research for the Future" Program).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 81-726-83-1221 (ext. 2645); Fax: 81-726-84-6516; E-mail: med001@art.osaka-med.ac.jp.

Published, JBC Papers in Press, March 12, 2001, DOI 10.1074/jbc.M101550200

    ABBREVIATIONS

The abbreviations used are: LCB, long chain base; EY, Eiko Yabuuchi; T, nomenclatural type strain for the species; PLP, pyridoxal 5'-phosphate; SPT, serine palmitoyltransferase; CoA, coenzyme A; KDS, 3-ketodihydrosphingosine; DPPC, dipalmitoylphosphatidylcholine; AEBSF, 4-(2-aminoethyl)-benzenesulfonyl fluoride; PCR, polymerase chain reaction; PAGE, polyacrylamide gel electrophoresis; ESI-MS, electrospray ionization mass spectrometry; AONS, 8-amino-7-oxononanoate synthase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Merrill, A. J., and Jones, D. D. (1990) Biochim. Biophys. Acta 1044, 1-12[Medline] [Order article via Infotrieve]
2. Huwiler, A., Kolter, T., Pfeilschifter, J., and Sandhoff, K. (2000) Biochim. Biophys. Acta 1485, 63-99[Medline] [Order article via Infotrieve]
3. Mandon, E. C., Ehses, I., Rother, J., van Echten, G., and Sandhoff, K. (1992) J. Biol. Chem. 267, 11144-11148[Abstract/Free Full Text]
4. Buede, R., Rinker, S. C., Pinto, W. J., Lester, R. L., and Dickson, R. C. (1991) J. Bacteriol. 173, 4325-4332[Medline] [Order article via Infotrieve]
5. Pinto, W. J., Srinivasan, B., Shepherd, S., Schmidt, A., Dickson, R. C., and Lester, R. L. (1992) J. Bacteriol. 174, 2565-2574[Abstract]
6. Nagiec, M. M., Baltisberger, J. A., Wells, G. B., Lester, R. L., and Dickson, R. C. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 7899-7902[Abstract]
7. Nagiec, M. M., Lester, R. L., and Dickson, R. C. (1996) Gene 177, 237-241[CrossRef][Medline] [Order article via Infotrieve]
8. Weiss, B., and Stoffel, W. (1997) Eur. J. Biochem. 249, 239-247[Abstract]
9. Hanada, K., Hara, T., Nishijima, M., Kuge, O., Dickson, R. C., and Nagiec, M. M. (1997) J. Biol. Chem. 272, 32108-32114[Abstract/Free Full Text]
10. Hanada, K., Hara, T., Fukasawa, M., Yamaji, A., Umeda, M., and Nishijima, M. (1998) J. Biol. Chem. 273, 33787-33794[Abstract/Free Full Text]
11. Hanada, K., Hara, T., and Nishijima, M. (2000) J. Biol. Chem. 275, 8409-8415[Abstract/Free Full Text]
12. Ikushiro, H., Hayashi, H., and Kagamiyama, H. (2000) in Biochemistry and Molecular Biology of Vitamin B6 and PQQ-dependent Proteins (Iriarte, A. , Kagan, H. M. , and Martinez-Carrion, M., eds) , pp. 251-254, Birkhauser Verlag, Basel, Switzerland
13. Batrakov, S. G., Sheichenko, V. I., and Nikitin, D. I. (1999) Biochim. Biophys. Acta 1440, 163-175[Medline] [Order article via Infotrieve]
14. Batrakov, S. G., Mosezhnyi, A. E., Ruzhitsky, A. O., Sheichenko, V. I., and Nikitin, D. I. (2000) Biochim. Biophys. Acta 1484, 225-240[Medline] [Order article via Infotrieve]
15. Lev, M., and Milford, A. F. (1981) Arch. Biochem. Biophys. 212, 424-431[Medline] [Order article via Infotrieve]
16. Yabuuchi, E., Tanimura, E., Kosako, Y., Ohyama, A., Yano, I., and Yamamoto, A. (1979) J. Gen. Appl. Microbiol. 25, 95-107
17. Yano, I., Tomiyasu, I., and Yabuuchi, E. (1982) FEMS Microbiol. Lett. 15, 303-307
18. Kawasaki, S., Moriguchi, R., Sekiya, K., Nakai, T., Ono, E., Kume, K., and Kawahara, K. (1994) J. Bacteriol. 176, 284-290[Abstract]
19. Yamamoto, A., Yano, I., Masui, M., and Yabuuchi, E. (1978) J. Biochem. (Tokyo) 83, 1213-1216[Abstract]
20. Williams, R. D., Wang, E., and Merrill, A. J. (1984) Arch. Biochem. Biophys. 228, 282-291[Medline] [Order article via Infotrieve]
21. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (1994) in Current Protocols in Molecular Biology, Suppl. 27, John Wiley & Sons, Inc., New York
22. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
23. Kallen, R. G., Korpela, T., Martell, A. E., Matsushima, Y., Metzler, C. M., Metzler, D. E., Morozov, Y. V., Ralston, I. M., Savin, F. A., Torchinsky, Y. M., and Ueno, H. (1985) in Transaminases (Christen, P. , and Metzler, D. E., eds) , pp. 37-108, John Wiley & Sons, New York
24. Segel, I. H. (1975) Enzyme Kinetics , pp. 505-515, John Wiley & Sons, Inc., New York
25. Altschul, S. F., Thomas, L. M., Alejandro, A. S., Jinghui, Z., Zheng, Z., Webb, M., and David, J. L. (1997) Nucleic Acids Res. 25, 3389-3402[Abstract/Free Full Text]
26. Gloeckler, R., Ohsawa, I., Speck, D., Ledoux, C., Bernard, S., Zinsius, M., Villeval, D., Kisou, T., Kamogawa, K., and Lemoine, Y. (1990) Gene (Amst.) 87, 63-70[CrossRef][Medline] [Order article via Infotrieve]
27. Ploux, O., and Marquest, A. (1992) Biochem. J. 283, 327-331[Medline] [Order article via Infotrieve]
28. Mukherjee, J. J., and Dekker, E. E. (1987) J. Biol. Chem. 262, 14441-14447[Abstract/Free Full Text]
29. Kunst, F., Ogasawara, N., Moster, I., Albertini, A. M., Alloni, G., Azevedo, V., Bertero, M. G., and Bessieres, P. (1997) Nature 390, 249-256[CrossRef][Medline] [Order article via Infotrieve]
30. Drolet, M., and Sasarman, A. (1991) Mol. Gen. Genet. 226, 250-256[Medline] [Order article via Infotrieve]
31. Yamamoto, A. (1982) J. Osaka City Med. Center 31, 201-219
32. Snell, E. E., Dimari, S. J., and Brady, R. N. (1970) Chem. Phys. Lipids 5, 116-138[CrossRef][Medline] [Order article via Infotrieve]
33. Alexeev, D., Alexeeva, M., Baxter, R. L., Campopiano, D. J., Webster, S. P., and Sawyer, L. (1998) J. Mol. Biol. 284, 401-419[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.